+44 (0)20 3910 4640 hello@symmetron.net

Idiopathic Pulmonary Fibrosis

 

Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource Use

PharmacoEconomics Open (2018) 1-10

Authors

Diamantopoulos A, Maher TM, Esser D, LeReun C

Process

\

Retrospective analysis of resource use data collected from two pivotal phase II trials

\

Logistic regression to identify associations between clinical- and -demographic factors and healthcare resource use

\

Results used to inform inputs of global reimbursement model

Publications in other disease areas

Atrial fibrillation

Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke

Cancer

Societal costs of Er+/Her2- advanced or metastatic breast cancer in post-menopausal women in the United Kingdom

Idiopathic pulmonary fibrosis

The burden of illness of idiopathic pulmonary fibrosis: a comprehensive evidence review

Psoriasis

The comparative efficacy of brodalumab in patients with moderate-to-severe psoriasis: a systematic literature review and network meta-analysis

Rheumatoid arthritis

Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK

 

Venous thromboembolism

Cost-effectiveness of rivaroxaban in the prevention of venous thromboembolism: A Canadian analysis using the Ontario Ministry of Health Perspective